tiprankstipranks
Trending News
More News >
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Financial Statements

Compare
314 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently $14.81M. The company's EPS TTM is $; its P/E ratio is -0.15; GT Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -12.42M$ -14.36M$ -13.58M$ -21.26M$ -57.52M
EBITDA$ -34.32M$ -13.16M$ 5.98M$ -20.96M$ -57.48M
Net Income$ -28.35M$ -13.16M$ -7.60M$ -20.88M$ -58.01M
Balance Sheet
Cash & Short-Term Investments$ 6.81M$ 3.95M$ 13.97M$ 16.51M$ 31.98M
Total Assets$ 8.11M$ 4.23M$ 14.11M$ 16.74M$ 32.17M
Total Debt$ 0.00$ 0.00$ 58.00K$ 174.00K$ 31.00K
Net Debt$ -6.81M$ -3.95M$ -1.02M$ -5.50M$ -8.94M
Total Liabilities$ 2.32M$ 5.90M$ 6.63M$ 5.00M$ 10.26M
Stockholders' Equity$ 5.79M$ -1.67M$ 7.48M$ 11.73M$ 21.91M
Cash Flow
Free Cash Flow$ -12.91M$ -12.90M$ -8.85M$ -15.22M$ -15.61M
Operating Cash Flow$ -12.91M$ -12.90M$ -8.85M$ -15.22M$ -15.61M
Investing Cash Flow$ 0.00$ 12.89M$ -2.01M$ 12.14M$ -23.04M
Financing Cash Flow$ 15.78M$ 2.98M$ 6.27M$ -224.00K$ 42.32M
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS